This federal contract award is for the delivery of XEOMIN 200 unit vials to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $20,114.64, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price and an ultimate completion date of February 6, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a...
This contract award is for the delivery of XEOMIN 200 unit vials to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price valued at $18,348.75 and an ultimate completion date of August 29, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds a $999,999,999...
This federal contract award is for the delivery of XEOMIN 100 unit vials to the Defense Logistics Agency (DLA). The $7,379.90 Firm Fixed Price Delivery Order was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract has no set-aside designation and was awarded under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC...
This federal contract award is for the delivery of XEOMIN 200 unit vials to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $10,485.00, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of June 18, 2024. The contract is not set aside and was awarded on a full and open competition...
This federal contract award is for the delivery of XEOMIN 100 unit vials to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $2,621.20. The contract is a delivery order with a firm fixed price, and the ultimate completion date is September 23, 2024. The place of performance is Conshohocken, PA. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of XEOMIN 100 unit vials to the Defense Logistics Agency (DLA). The $10,847.20 firm fixed-price delivery order was awarded on November 26, 2024 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has an ultimate completion date of December 18, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This federal contract award is for the procurement of XEOMIN 100 unit vials, a pharmaceutical product, by the Defense Logistics Agency (DLA). The $6,704.88 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 10, 2025 and was awarded on February 14, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of XEOMIN 100 unit vials to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $1,627.08 and a ceiling value of $1,627.08. The ultimate completion date is January 9, 2025. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of XEOMIN 100 unit vials to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on January 24, 2025, with a ceiling value of $2,234.96 and a completion date of February 14, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation,...
This federal contract award to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) provides for the delivery of XEOMIN 200 unit vials. The $7,863.60 firm-fixed-price delivery order, awarded on November 5, 2024, has a period of performance through November 27, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which covers a comprehensive range of pharmaceutical products and medical supplies for military...